Background With the advent of COVID-19, mortality rates of end-stage kidney disease
(ESKD) rose by 37% which makes its treatment an important part of healthcare …

Background With rising incidence and increased life expectancy of patients with chronic
kidney disease (CKD) and end-stage renal disease (ESRD), the number of patients …

Introduction: Arteriovenous fistulas (AVF) are the preferred choice for vascular access in
hemodialysis. We aim to identify factors that may contribute to AVF failure. Methods: Data …

End-stage renal disease (ESRD) is prevalent in our region. A major mode of treatment is by
maintenance hemodialysis, and reliable vascular access is paramount for this to be …

Abstract Aim The recent IN. PACT AV Access study found drug‐coated balloon therapy to be
associated with reduced reinterventions compared to percutaneous transluminal …

Purpose Considering various factors, such as multiple co-morbidities, unsuitable vessels for
access creation, non-maturation, vascular calcifications, the outcome of arteriovenous fistula …

Introduction End-stage kidney disease (ESKD) patients require life-sustaining kidney
replacement therapies, with the natural arteriovenous fistula (AVF) being the preferred …

Introduction: A functioning and reliable arteriovenous fistula is a lifeline for individuals
suffering from chronic kidney disease. The success and failure to arteriovenous fistula …

Introduction: Arteriovenous fistula is considered as gold standard access for maintenance
hemodialysis. Due to increasing burden of end-stage renal disease requiring dialysis, it is …

Results: A total of 119 AVFs (anchor technique= 65, parachute technique= 54) were
included in the study. The aggregated primary patency at 6 weeks and 6 months was 85.7 …